OPIPARI ANTHONY W. (See Remarks) exercised options at ODYSSEY THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
Common Stock
Shares
+6.96K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+541.00
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−4.00
Price / share
$18.00
Trade value
$72.00
% of position
Net shares
+7.50K
Net value
-$72.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | C · Conversion | +6.96K | — | — | New position | 0.00 | 6.96K |
| Common Stock Direct | 5/11/2026 | M · Option Exercise | +541.00 | — | — | 7.8% | 6.96K | 7.51K |
| Common Stock Direct | 5/11/2026 | F · Tax Withholding | −4.00 | $18.00 | $72.00 | 0.1% | 7.51K | 7.50K |
| Total | +7.50K | -$72.00 | ||||||
Stock Option (Right to Buy)
Common Stock
250.20K shares
Shares
+250.20K
Strike price
18.00
Held after
250.20K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
27.78K shares
Shares
+27.78K
Strike price
18.00
Held after
27.78K
Exercisable
—
Series A Convertible Preferred Stock
Common Stock
1.91K shares
Shares
−18.53K
Strike price
Held after
0.00
Exercisable
—
Series B Convertible Preferred Stock
Common Stock
1.19K shares
Shares
−11.08K
Strike price
Held after
0.00
Exercisable
—
Series C Convertible Preferred Stock
Common Stock
2.06K shares
Shares
−20K
Strike price
Held after
0.00
Exercisable
—
Series D Convertible Preferred Stock
Common Stock
1.81K shares
Shares
−17.55K
Strike price
Held after
0.00
Exercisable
—
Series D Warrants (Right to Buy)
Common Stock
541.00 shares
Shares
−5.26K
Strike price
0.10
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock250.20K shares | 5/7/2026 | A · Award | +250.20K | 18.00 | — | 250.20K |
| Stock Option (Right to Buy) Direct | Common Stock27.78K shares | 5/7/2026 | A · Award | +27.78K | 18.00 | — | 27.78K |
| Series A Convertible Preferred Stock Direct | Common Stock1.91K shares | 5/11/2026 | C · Conversion | −18.53K | — | 0.00 | |
| Series B Convertible Preferred Stock Direct | Common Stock1.19K shares | 5/11/2026 | C · Conversion | −11.08K | — | 0.00 | |
| Series C Convertible Preferred Stock Direct | Common Stock2.06K shares | 5/11/2026 | C · Conversion | −20K | — | 0.00 | |
| Series D Convertible Preferred Stock Direct | Common Stock1.81K shares | 5/11/2026 | C · Conversion | −17.55K | — | 0.00 | |
| Series D Warrants (Right to Buy) Direct | Common Stock541.00 shares | 5/11/2026 | M · Option Exercise | −5.26K | 0.10 | — | 0.00 |